51 and 75 per cent of subjects at any one follow up visit. There were 19 withdrawals from the treatment group, 10 of which were the result of side effects. There were 5 withdrawals from the control group. According to the original intention to treat, there were 18 deaths at 2 years in the treatment group and 14 deaths in the control group. There was no reduction in the incidence of instantaneous or sudden deaths. Deaths on treatment were not associated with a low phenytoin plasma level. Phenytoin treatment showed no beneficial effects on mortality and was associated with a high incidence of side effects.
suMMARY Nine hundred and sixty-nine coronary care patients with acute myocardial infarction were followed for one year. Atrial fibrillation was documented in 107 patients. Compared with patients without atrial fibrillation, those with this arrhythmia were older, had clinically more severe infarction, and had a higher frequency of ventricular fibrillation or tachycardia, and right bundle-branch block. They had similar past histories of ischaemic heart disease and coronary risk factors. Patients with atrial fibrillation had a higher total mortality at 3 months and 12 months. The presence of atrial fibrillation was not associated with any significant increase in mortality within any decade of age or within any subgroup of clinical severity of infarction. The frequency of atrial fibrillation was similar in anterior and inferior infarction. Multiple episodes of atrial fibrillation occurred in 52 patients and episodes usually lasted for over 1 hour. In 50 per cent of patients with single episodes of atrial fibrillation the initial ventricular rate was greater than 120 beats per minute.The association of atrial fibrillation with acute myocardial infarction is known to carry a high mortality (Stannard and Sloman, 1967;Klass and Haywood, 1970;Helmers et al., 1973;Cristal et al., 1976;Liberthson et al., 1976). It is unlikely that this high mortality is the result of the arrhythmia itself but is more likely the result of the clinical situation in which atrial fibrillation develops. Thus atrial fibrillation is usually associated with older patients and with clinically more severe infarction (Stannard and Sloman, 1967;Klass and Haywood, 1970;Helmers et al., 1973;Cristal et al., 1976;Liberthson et al., 1976 as necessary and intranasal oxygen given at a rate of 2 1/min for the first 12 hours. The patients' rhythms were displayed on multichannel oscilloscopes in a central nurses' station. Ten-second electrocardiograph strips were recorded every hour for the first 2 days and more often if arrhythmias were detected. A 4-channel tape recorder was available for part of the period under study. Blood was taken and measurements made of creatine kinase and aspartate transaminase on admission and then daily for at least 2 days. Routine 12-lead electrocardiograms and 2 metre posteroanterior chest radiographs with the patient sitting on the side of the bed were made on admission, daily for the first 2 days, and then according to need.
A computerized database for pacemaker follow-up has been designed to run on IBM compatible hardware and to accept pulse generator and lead models of all manufacturers. Stored data includes patient, physician and implant details, indications for pacing, underlying rhythm, complications and management, program settings, and follow-up measurements. Typing is minimized by the use of "pop-up" lists and prepared pulse generator template displays. At each follow-up visit a patient's file is retrieved by surname or number, a visit record created, and measurements documented. As the template of the previous visit is used, recording of the clinic visit takes less than 1 minute. Changes in pacing rates (base or magnet), pulse widths, lead thresholds, lead impedance, and battery cell impedance can be displayed graphically for immediate recognition of end-of-life parameters or suspected malfunction. The program will print patient, implantation and clinic visit summary reports, clinic appointment lists, letters to patients, and annual reports. Two Melbourne hospitals have now entered over 3,600 patients into the database. Valuable information has been obtained regarding implantation details and trends with pulse generator and lead usage. Pacecare is a sophisticated, yet user friendly, computerized database for pacemaker follow-up. Recording of clinic visits is fast and changes in testing parameters can be recognized immediately.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.